vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Via Renewables, Inc. (VIASP). Click either name above to swap in a different company.

Via Renewables, Inc. is the larger business by last-quarter revenue ($127.8M vs $75.1M, roughly 1.7× MEDIFAST INC). On growth, Via Renewables, Inc. posted the faster year-over-year revenue change (22.5% vs -36.9%). Via Renewables, Inc. produced more free cash flow last quarter ($-4.8M vs $-6.6M). Over the past eight quarters, Via Renewables, Inc.'s revenue compounded faster (5.9% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

EDF Power Solutions is a wholly owned subsidiary of the French utility EDF Group, specializing in renewable energy production. As an integrated operator, the Group develops and finances the construction of renewable energy facilities, and manages operations and maintenance for its own account and for third parties.

MED vs VIASP — Head-to-Head

Bigger by revenue
VIASP
VIASP
1.7× larger
VIASP
$127.8M
$75.1M
MED
Growing faster (revenue YoY)
VIASP
VIASP
+59.4% gap
VIASP
22.5%
-36.9%
MED
More free cash flow
VIASP
VIASP
$1.9M more FCF
VIASP
$-4.8M
$-6.6M
MED
Faster 2-yr revenue CAGR
VIASP
VIASP
Annualised
VIASP
5.9%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
VIASP
VIASP
Revenue
$75.1M
$127.8M
Net Profit
$6.9M
Gross Margin
69.4%
34.4%
Operating Margin
-10.4%
15.2%
Net Margin
5.4%
Revenue YoY
-36.9%
22.5%
Net Profit YoY
-30.9%
EPS (diluted)
$-1.64
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
VIASP
VIASP
Q4 25
$75.1M
$127.8M
Q3 25
$89.4M
$103.3M
Q2 25
$105.6M
$90.0M
Q1 25
$115.7M
$142.3M
Q4 24
$119.0M
$104.3M
Q3 24
$140.2M
$93.8M
Q2 24
$168.6M
$86.7M
Q1 24
$174.7M
$114.1M
Net Profit
MED
MED
VIASP
VIASP
Q4 25
$6.9M
Q3 25
$-2.3M
$757.0K
Q2 25
$2.5M
$2.7M
Q1 25
$-772.0K
$8.8M
Q4 24
$9.9M
Q3 24
$1.1M
$2.1M
Q2 24
$-8.2M
$7.6M
Q1 24
$8.3M
$8.6M
Gross Margin
MED
MED
VIASP
VIASP
Q4 25
69.4%
34.4%
Q3 25
69.5%
23.1%
Q2 25
72.6%
30.0%
Q1 25
72.8%
32.9%
Q4 24
74.1%
51.9%
Q3 24
75.4%
26.8%
Q2 24
73.2%
50.4%
Q1 24
72.8%
39.5%
Operating Margin
MED
MED
VIASP
VIASP
Q4 25
-10.4%
15.2%
Q3 25
-4.6%
3.1%
Q2 25
-1.0%
6.7%
Q1 25
-1.1%
17.5%
Q4 24
0.6%
31.5%
Q3 24
1.5%
5.3%
Q2 24
-4.7%
23.8%
Q1 24
4.5%
22.6%
Net Margin
MED
MED
VIASP
VIASP
Q4 25
5.4%
Q3 25
-2.5%
0.7%
Q2 25
2.3%
3.0%
Q1 25
-0.7%
6.2%
Q4 24
9.5%
Q3 24
0.8%
2.3%
Q2 24
-4.8%
8.8%
Q1 24
4.8%
7.5%
EPS (diluted)
MED
MED
VIASP
VIASP
Q4 25
$-1.64
$1.19
Q3 25
$-0.21
$-0.41
Q2 25
$0.22
$0.09
Q1 25
$-0.07
$1.83
Q4 24
$0.08
$2.33
Q3 24
$0.10
$-0.17
Q2 24
$-0.75
$1.51
Q1 24
$0.76
$1.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
VIASP
VIASP
Cash + ST InvestmentsLiquidity on hand
$167.3M
$41.8M
Total DebtLower is stronger
$120.0M
Stockholders' EquityBook value
$198.9M
$67.7M
Total Assets
$248.0M
$331.3M
Debt / EquityLower = less leverage
1.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
VIASP
VIASP
Q4 25
$167.3M
$41.8M
Q3 25
$173.5M
$53.6M
Q2 25
$162.7M
$62.1M
Q1 25
$164.6M
$64.7M
Q4 24
$162.3M
$53.1M
Q3 24
$170.0M
$66.6M
Q2 24
$163.5M
$53.6M
Q1 24
$156.4M
$50.4M
Total Debt
MED
MED
VIASP
VIASP
Q4 25
$120.0M
Q3 25
$105.0M
Q2 25
$100.0M
Q1 25
$101.0M
Q4 24
$106.0M
Q3 24
$89.0M
Q2 24
$93.0M
Q1 24
$91.0M
Stockholders' Equity
MED
MED
VIASP
VIASP
Q4 25
$198.9M
$67.7M
Q3 25
$214.7M
$63.7M
Q2 25
$216.0M
$68.2M
Q1 25
$211.0M
$72.7M
Q4 24
$210.1M
$66.7M
Q3 24
$207.3M
$58.2M
Q2 24
$205.3M
$58.3M
Q1 24
$211.0M
$53.2M
Total Assets
MED
MED
VIASP
VIASP
Q4 25
$248.0M
$331.3M
Q3 25
$268.2M
$304.8M
Q2 25
$269.3M
$316.3M
Q1 25
$280.0M
$347.4M
Q4 24
$284.2M
$344.9M
Q3 24
$291.2M
$298.4M
Q2 24
$293.5M
$299.7M
Q1 24
$302.8M
$302.7M
Debt / Equity
MED
MED
VIASP
VIASP
Q4 25
1.77×
Q3 25
1.65×
Q2 25
1.47×
Q1 25
1.39×
Q4 24
1.59×
Q3 24
1.53×
Q2 24
1.60×
Q1 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
VIASP
VIASP
Operating Cash FlowLast quarter
$-5.3M
$-4.2M
Free Cash FlowOCF − Capex
$-6.6M
$-4.8M
FCF MarginFCF / Revenue
-8.8%
-3.7%
Capex IntensityCapex / Revenue
1.8%
0.4%
Cash ConversionOCF / Net Profit
-0.61×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$39.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
VIASP
VIASP
Q4 25
$-5.3M
$-4.2M
Q3 25
$12.1M
$2.4M
Q2 25
$-3.4M
$19.0M
Q1 25
$3.4M
$24.9M
Q4 24
$-4.9M
$2.0M
Q3 24
$9.1M
$20.1M
Q2 24
$13.1M
$11.2M
Q1 24
$7.3M
$17.1M
Free Cash Flow
MED
MED
VIASP
VIASP
Q4 25
$-6.6M
$-4.8M
Q3 25
$10.8M
$1.9M
Q2 25
$-4.8M
$18.4M
Q1 25
$1.9M
$23.5M
Q4 24
$-7.2M
$1.6M
Q3 24
$7.7M
$19.7M
Q2 24
$11.1M
$10.9M
Q1 24
$5.4M
$16.6M
FCF Margin
MED
MED
VIASP
VIASP
Q4 25
-8.8%
-3.7%
Q3 25
12.0%
1.9%
Q2 25
-4.5%
20.5%
Q1 25
1.6%
16.5%
Q4 24
-6.1%
1.5%
Q3 24
5.5%
21.0%
Q2 24
6.6%
12.6%
Q1 24
3.1%
14.6%
Capex Intensity
MED
MED
VIASP
VIASP
Q4 25
1.8%
0.4%
Q3 25
1.5%
0.4%
Q2 25
1.3%
0.6%
Q1 25
1.3%
1.0%
Q4 24
1.9%
0.4%
Q3 24
1.0%
0.4%
Q2 24
1.1%
0.3%
Q1 24
1.1%
0.4%
Cash Conversion
MED
MED
VIASP
VIASP
Q4 25
-0.61×
Q3 25
3.12×
Q2 25
-1.36×
6.94×
Q1 25
2.84×
Q4 24
0.20×
Q3 24
8.04×
9.41×
Q2 24
1.47×
Q1 24
0.88×
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

VIASP
VIASP

Retail Electricity$79.7M62%
Retail Natural Gas$48.9M38%

Related Comparisons